The Latest Breaking News from Vaccine

Doctors attribute rise in test results to high number of pupils infected with Omicron during spring term

BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher by 6.31% at $142.50 after the company announced its Omicron-adapted COVID-19 vaccine candidates demonstrated high immune response against the Omicron variant.

U.S. health authorities are facing a critical decision: whether to offer new COVID-19 booster shots this fall that are modified to better match the latest changes of the shape-shifting coronavirus

Vaccine to be given to four to eight month old calves

Until an infectious disease is eradicated everywhere in the world, we are all vulnerable, says Devi Sridhar of the University of Edinburgh

While COVID-19 vaccines continue to be highly effective at preventing hospitalization and death, it has become clear that the protection offered by the current vaccines wanes over time. This necessitates the use of booster shots that are safe and effective in enhancing the immune response against the virus and extending…

BEIJING: China's Clover Biopharmaceuticals said on Monday a booster shot of its Covid-19 vaccine candidate significantly increased antibody response against the Omicron coronavirus variant from levels seen after two primary shots.

The survey data was released today

Study finds more primary parents are wary of vaccinating their child against Covid than in 2021.

A Federal Court judge says litigation against the Commonwealth, states and NT over lockdown and vaccine mandates was an abuse of process.

Hajj 2022 begins on Thursday, July 7